W. Thorpe Mckenzie - Dec 16, 2021 Form 4 Insider Report for XBiotech Inc. (XBIT)

Role: Director, 10%+ Owner
Signature: /s/Queena Han under Power of Attorney for W. Thorpe McKenzie
Stock symbol: XBIT
Transactions as of: Dec 16, 2021
Transactions value $: -$3
Form type: 4
Date filed: 1/13/2022, 11:18 AM
Previous filing: Jun 24, 2021
Next filing: Jun 27, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XBIT	Common Stock	Options Exercise	$2.5M	+250K	+9.76%	$10.00	2.81M	Dec 16, 2021	Direct
transaction	XBIT	Common Stock	Tax liability	-$2.5M	-213K	-7.6%	$11.71	2.6M	Dec 16, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XBIT	Stock Option	Options Exercise	$0	-250K	-43.86%	$0.00	320K	Dec 16, 2021	Common Stock	250K	$10.00	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a "net exercise" of outstanding stock options. The reporting person received 36,507 shares of common stock on net exercise of option to purchase 250,000 shares of common stock. The Company withheld 213,493 shares of common stock underlying the option for payment of the exercise price using the closing stock price on December 16, 2021 of $11.71, pursuant to the terms of the 2005 Equity Incentive Plan.

Content

Represents a "net exercise" of outstanding stock options. The reporting person received 36,507 shares of common stock on net exercise of option to purchase 250,000 shares of common stock. The Company withheld 213,493 shares of common stock underlying the option for payment of the exercise price using the closing stock price on December 16, 2021 of $11.71, pursuant to the terms of the 2005 Equity Incentive Plan.